OPEN END TURBO BULL OPTIONSSCHEIN - ASTRAZENECA | Real-time Bid/Ask 05:34:26 03/05/2024 pm IST | ||
| 5.77 EUR / 5.78 EUR | -0.26% |
|
| Current month | +2.66% | ||
| 1 month | +42.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 5.68 | -1.90% | 0 |
| 02/24/02 | 5.79 | +2.66% | 0 |
| 30/24/30 | 5.64 | -2.93% | 0 |
| 29/24/29 | 5.81 | +2.83% | 0 |
| 26/24/26 | 5.65 | +0.18% | 0 |
Delayed Quote Börse Stuttgart
Last update May 03, 2024 at 02:42 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HR8WWG |
| ISIN | DE000HR8WWG9 |
| Date issued | 27/07/2021 |
| Strike | 7,181 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.29 € |
|---|---|
| Lowest since issue | 1.88 € |
| Spread | 0.01 € |
| Spread % | 0.17% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
151.9
USD
Average target price
164.5
USD
Spread / Average Target
+8.29%
- Stock Market
- Certificates
- Certificat
